Makale, 2025
Evaluation of hsa-miR-29a-3p expression and diazepam biotransformation via CYP2C19 in alcohol withdrawal syndrome
Environmental Toxicology and Pharmacology, 120, 104861
- Atıf
- 0 (Crossref)
Kaynak gösterimi
Tezcan, T., Özkan-Kotiloğlu, S., Yıldırım, M. A., Danışman, M., Bozmaoğlu, H. C., Tok, K. C., Kar, İ., Gümüştaş, M., Özgür-İlhan, İ., Süzen, H. S., & Kaya-Akyüzlü, D. (2025). Evaluation of hsa-miR-29a-3p expression and diazepam biotransformation via CYP2C19 in alcohol withdrawal syndrome. Environmental Toxicology and Pharmacology, 120, 104861. https://doi.org/10.1016/j.etap.2025.104861
Tezcan T, Özkan-Kotiloğlu S, Yıldırım MA, Danışman M, Bozmaoğlu HC, Tok KC, et al. Evaluation of hsa-miR-29a-3p expression and diazepam biotransformation via CYP2C19 in alcohol withdrawal syndrome. Environmental Toxicology and Pharmacology. 2025;120:104861. doi:10.1016/j.etap.2025.104861
Tezcan, Tuğba, Selin Özkan-Kotiloğlu, Mukaddes Asena Yıldırım, Mustafa Danışman, H. Ceren Bozmaoğlu, Kenan Can Tok, İrem Kar, et al. 2025. “Evaluation of hsa-miR-29a-3p expression and diazepam biotransformation via CYP2C19 in alcohol withdrawal syndrome.” Environmental Toxicology and Pharmacology 120: 104861. https://doi.org/10.1016/j.etap.2025.104861.
Tezcan, Tuğba, et al. “Evaluation of hsa-miR-29a-3p expression and diazepam biotransformation via CYP2C19 in alcohol withdrawal syndrome.” Environmental Toxicology and Pharmacology, vol. 120, 2025, p. 104861. https://doi.org/10.1016/j.etap.2025.104861.
Tezcan, T., Özkan-Kotiloğlu, S., Yıldırım, M.A., Danışman, M., Bozmaoğlu, H.C., Tok, K.C., Kar, İ., Gümüştaş, M., Özgür-İlhan, İ., Süzen, H.S. and Kaya-Akyüzlü, D. (2025) ‘Evaluation of hsa-miR-29a-3p expression and diazepam biotransformation via CYP2C19 in alcohol withdrawal syndrome’, Environmental Toxicology and Pharmacology, 120, p. 104861. doi:10.1016/j.etap.2025.104861.